D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways-Reference-Cited by-同舟云学术

D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways

Published:2008-01-31 Issue:5 Volume:582 Page:603-610
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Chen Sheng,Zhang Xiaojie,Yang Dehua,Du Yunlan,Li Liang,Li Xuping,Ming Ming,Le Weidong

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference29 articles.

1. Neuroprotective therapy for Parkinson’s disease;Chen;Am. J. Ther.,2006

2. Apoptosis in Parkinson’s disease: signals for neuronal degradation;Tatton;Ann. Neurol.,2003

3. How many pathways are there to nigral death?;Hardy;Ann. Neurol.,2004

4. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats;Alam;Behav. Brain Res.,2002

5. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease;Betarbet;Nat. Neurosci.,2000

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demotion of canonical/non-canonical inflammasome and pyroptosis alleviates ischemia/reperfusion-induced acute kidney injury: Novel role of the D2/D3 receptor agonist ropinirole;European Journal of Pharmacology;2024-04

2. Ropinirole inhibits inflammatory cytokine production in gingival epithelial cells and suppresses alveolar bone loss in an experimental rat model of periodontitis;Experimental and Therapeutic Medicine;2022-12-29

3. Crafting ɣ-L-Glutamyl-l-Cysteine layered Human Serum Albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia/reperfusion injury via “3A approach”;Biomaterials;2022-10

4. Parkinsonian Drugs in China;NeuroPsychopharmacotherapy;2022

5. In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist;ACS Omega;2021-12-06